Keyphrases
Acute Myeloid Leukemia
15%
Anaplastic Thyroid Cancer
11%
Breast Cancer
30%
Breast Cancer Treatment
11%
Cancer Genomics
11%
Cancer Variants
18%
Clinical Genome Resource
15%
Clinical Interpretation
26%
Clinically Significant
12%
Clonal Architecture
12%
Community-based
12%
Crowdsourcing
13%
Curation
17%
Differentiated Thyroid Cancer
15%
Drug-gene Interaction
18%
ER+ Breast Cancer
11%
Estrogen
18%
Estrogen Receptor-positive Breast Cancer
12%
Follicular Lymphoma
12%
Gene Expression Profiling
11%
Gene Regulation
11%
Genome Analysis
13%
Genome Sequencing
12%
Genomic Data
13%
Genomic Landscape
12%
Head-and-neck Cancer
13%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
14%
In Cancer
53%
Interaction Database
18%
Memory-like
12%
Molecular Markers
13%
Natural Killer Cells
14%
Neoadjuvant
23%
Neoantigen
32%
Neoantigen Prediction
12%
Order-preserving Submatrix
11%
Pathological Complete Response
10%
Phase II Trial
11%
Prognostic Biomarker
11%
RNA Sequencing (RNA-seq)
26%
Sequence Data
12%
Somatic mutation
24%
Somatic Variants
24%
Therapeutic Target
12%
Thyroid Cancer
13%
Thyroid Tumor
13%
Transcriptome
11%
Triple-negative Breast Cancer
11%
Tumor
58%
Variant Interpretation
35%
Biochemistry, Genetics and Molecular Biology
Allele
11%
B Cell
9%
Binding Site
13%
Bioinformatics
8%
Cancer Cell
31%
Cancer Genomics
15%
Clinical Trial
17%
Deep Sequencing
16%
Drug Resistance
11%
Estrogen Receptor
17%
Exome
15%
Exome Sequencing
18%
Gene Control
14%
Gene Expression
28%
Gene Expression Profiling
28%
Gene Frequency
12%
Gene Interaction
15%
Gene Mutation
7%
Genetic Marker
20%
Genetics
17%
Genome Sequencing
9%
Genomics
100%
Germ Cell
16%
Germline
16%
Immunity
10%
Isoform
16%
Kinase
8%
Medline
9%
Messenger RNA
11%
Mutated Genes
8%
Myeloid
10%
Oncogene
8%
P53
8%
Peptide Sequence
9%
Phosphotransferase
8%
Promoter Region
7%
Random Forest
9%
Regulatory Element
11%
RNA
19%
RNA Sequence
26%
RNA Sequencing
18%
Somatic Mutation
25%
T Cell
20%
Tissue Microarray
11%
Transcription Factors
15%
Transcriptome
14%
Tumor Gene
7%
Tumor Marker
11%
Tumor Progression
16%
Whole Genome Sequencing
14%
Medicine and Dentistry
Acute Myeloid Leukemia
12%
Adenoma
11%
Anaplastic Thyroid Carcinoma
7%
Anastrozole
7%
Biological Marker
17%
Breast Cancer
34%
Breast Cancer Cell Line
6%
Cancer Biomarkers
6%
Clinical Significance
7%
Clinical Stage
8%
Clinical Trial
6%
Cytotoxic T-Cell
6%
Diagnosis
25%
Differentiated Thyroid Cancer
16%
Diffuse Large B-Cell Lymphoma
7%
Diseases
12%
Exome Sequencing
14%
Follicular Lymphoma
12%
Gene Expression Profiling
11%
Genome Sequencing
7%
Growth Factor Receptor
7%
Head and Neck Cancer
11%
Head and Neck Squamous Cell Carcinoma
7%
Health Care Cost
6%
Hematopoietic Cell
7%
Immune Checkpoint Blockade
6%
Immunity
8%
Malignant Neoplasm
72%
Medicine
13%
Meta-Analysis
7%
Metastatic Carcinoma
6%
Molecular Marker
11%
Natural Killer Cell
15%
Neoplasm
69%
Oncology
6%
Pembrolizumab
7%
Phase II Trials
11%
RNA Sequence
7%
RNA Sequencing
6%
Somatic Mutation
14%
Somatics
24%
T Cell
7%
Thyroid Cancer
14%
Thyroid Gland
13%
Thyroid Tumor
15%
Treatment Response
6%
Triple Negative Breast Cancer
7%
Tumor Cell
6%
Tumor Gene
8%
Tumor Progression
7%